ArticleAnnals of hematology2024
GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.
Yanfeng Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.